GW25-e3243 Sanguinarine Inhibited Ang II Induced Apoptosis in H9c2 Cardiac Cells via Restoring ROS-decreased Mitochondrial Membrane Potential  by Yuan, Liu & Tang, Qizhu
expression of sh-CTSB or over-expressed CTSB by lentiviral vector to further conﬁrm
the in vivo results.
Results: Our data demonstrated that knockout of CTSB attenuated pressure overload-
induced cardiac hypertrophy, ﬁbrosis, and dysfunction. Further studies showed that
pressure overload signiﬁcantly induced the activation of c-Jun N-terminal kinase
(JNK) signaling, which was blocked in CTSB-KO hearts. Mechanistically, we also
discovered that the expression levels of apoptosis-related proteins, Bax, Bid and
cleaved caspase3, cleaved caspase 9 being remarkably decreased in CTSB-KO hearts
after aortic banding, compared with control hearts, while anti-apoptotic protein, Bcl-2
was signiﬁcantly increased in CTSB-KO hearts after aortic banding. Similar results
were observed in cultured CTSB-deﬁcient H9c2 cardiomyocytes after the treatment
with angiotensin II, whereas the CTSB-overexpressed H9c2 cardiomyocytes displayed
the opposite phenotype.
Conclusions: These studies indicate that CTSB protein is a crucial component of the
signaling pathway involved in cardiac remodeling, which may be associated with
JNK/c-jun pathway and cell apoptosis.
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Objectives: Cell apoptosis induced by Angiotensin II (Ang II) plays a critical role in
the development of cardiovascular diseases. The study was to investigate whether
sanguinarine (SAN) can abolish Ang II induced cell apoptosis.
Methods: When H9c2 cells received different factor intervention for 24h; the toxicity
of SAN on H9c2 cells was determined by Cell Counting Kit CCK-8 assay; the level of
intracellular ROS generation was accessed using DCFH-DA; The change of mito-
chondrial membrane potential (MMP) was accessed using JC-1; the mRNA expres-
sion of NOX2 was test by RT-PCR; apoptosis was evaluated was determined using
ﬂuorescence-activated cell sorting (FACS); Western blot domenstrated the protein
associated with apoptosis; The activity of caspase-3 and caspase-9 was accessed using
the caspase-3 and caspase-9 activity kit.
Results: H9c2 cardiomyocytes were stimulated with 1mmol/L Ang II with or without
sanguinarine/N-Acetyl-L-cysteine (NAC), respectively. Our results showed that san-
guinarine inhibited the increase of NOX2 index and ROS generation, and ameliorated
mitochondrial membrane potential (MMP) lose induced by Ang II in H9c2. It has also
been shown that caspase-3 and caspase-9 proteins expression and activity were
decreased, and Bcl-2/Bax ratio was enhanced accordingly.
Conclusions: Our ﬁndings indicate that sanguinarine could inhibite H9c2 cardiac cells
apoptosis caused by Ang II and most likely is a result of restoring ROS-decreased
mitochondrial membrane potential.
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Objectives: To explore the role of mitochondrial KATP in high glucose- induced
apoptosis in cardiomyocytes.
Methods: Pretreatments of diazoxide (DZ) or 5-hydroxy- decanoic acid (5-HD) were
administrated to primary rat myocytes before high-glucose incubation. Mitochondrial
activity was assessed by MTT method; mitochondrial membrane potential (MMP) and
cell apoptosis were evaluated by ﬂow cytometry; Western-Blot was applied to detect
the expressions of cytochrome C and cleaved caspases-3.
Results: Compared with normal control and DZ pretreatment, high-glucose incuba-
tion signiﬁcantly increased cell apoptotic percentage, at the same time, mitochondrial
activity was inhibited, MMP decreased, expressions of cytochrome C and caspase-3
increased signiﬁcantly (all P<0.05). Compared with high-glucose incubation, pre-
treatment of 5-HD further increased apoptotic percentage, inhibited mitochondrial
activity, decreased MMP and increased expressions of cytochrome C and caspase-3
increased signiﬁcantly (all P<0.05).
Conclusions: Under high-glucose environment, mitoKATP in myocytes affects mito-
chondrial activity and integrity by impacting MMP, then induces apoptosis via
mitochondria-dependent pathway.
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Objectives: The present study examined the effect of atorvastatin on CRP-induced
apoptosis in human umbilical vein endothelial cells.
Methods: The HUVECs were cultured in vitro. Apoptosis of HUVECs were observed
by acridine orange/ethidium bromide ﬂuorescence staining. After HUVECs wereJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Bincubated with different concentrations of CRP (5ug/mL, 10ug/mL, 20ug/mL) and
atorvastatin (0.1mmol/L, 1mmol/L, 10mmol/L) for 24 hours. The early apoptosis rates
were detected respectively by ﬂow cytometry. The expression of Bcl-2/Bax and P53
were detected respectively by RT-PCR and western blotting.
Results: Treated with different concentrations of CRP after 24 hours, the early
apoptosis rates of HUVECs gradually increased with concentration-dependted.
Compared with the control group (0.640.06%), the early apoptosis rates of 5 ug / mL
CRP group, 10 ug / mL CRP group and 20ug/mL CRP respectively were
(2.500.44%, 8.070.7%, 12.840.77%, respectively), there were a statistically
signiﬁcant difference (P<0.01). Compared with 10mg/L CRP group, the early
apoptosis rates of 20mg/L CRP group also increased signiﬁcantly (P <0.01). In
different concentrations of CRP for 24 hours, the expression of Bcl-2 protein
decreased gradually. However, the protein expression of Bax and P53 were increased.
The ratios of Bcl-2/Bax and P53/ Bax were gradually decreased. There were statis-
tically signiﬁcant differences between experimental group and control group
(P <0.01). Treated with 20ug/mL CRP and different concentrations of atorvastatin
24 hours later, compared with 20mg/L CRP group, the early apoptosis rates of
HUVECs of atorvastatin intervention group gradually decreased with concentration-
dependted. The early apoptosis rate of HUVECs of 0.1mmol/L atorvastatin group,
1mmol/L atorvastatin group and 10mmol/L atorvastatin group respectively were
10.450.74%, 8.380.6% and 7.350.44%. Compared with 20mg/L CRP group, the
early apoptosis rate of the high and middle concentrations of atorvastatin group were
signiﬁcantly decreased (P<0.01). There were also statistically signiﬁcant difference
between middle concentration of atorvastatin group and high concentrations of ator-
vastatin group (P<0.01). With concentration-dependted of atorvastatin, the expression
of Bcl-2 protein gradually increased, the protein expression of Bax and P53 gradually
decreased; the ratio of Bcl -2/Bax gradually decreased, the ratio of P53/Bax also
decreased gradually. Compared with the 20ug/mL CRP, there were statistically sig-
niﬁcant difference in the expression of Bcl-2 protein, Bax protein and P53 protein of
the middle and high concentrations of atorvastatin group (P<0.01). The ratio of P53/
Bax of high concentrations of atorvastatin group was statistically signiﬁcant compared
with the 20ug/mL CRP (P <0.01).
Conclusions: The CRP can induce apoptosis in HUVECs, which is connected with
up-regulating the expression of P53 protein and Bax protein, down-regulating the
expression of Bcl-2 protein. Middle and high concentrations of atorvastatin prob-
ably inhibit the apoptosis in human umbilical vein endothelial cells induced by CRP
though up-regulating expression of Bcl-2 protein, down-regulating expression of
P53 protein and Bax protein. Expression of Bcl-2 protein maybe negativly modu-
lates expression of Bax protein. P53 protein maybe regulates the activation of Bax
protein.
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Objectives: Sphingosine 1-phosphate (S1P) generated by sphingosine kinases (SphK)
regulates multiple pathophysiological processes in cardiovascular system. However,
the role of SphK/S1P axis involved in heart failure remains unclear. The study was
designed to investigate the role of S1P signaling in myocardial infarction (MI) induced
heart failure and the underlying mechanisms.
Methods: Male C57BL/6J mice were subjected to permanent left coronary artery
occlusion and were randomized to receive vehicle, FTY720 (3mg/kg, i.P. daily) and
ABC294640 (5mg/kg, i.P. daily) treatment for 4 weeks. Cardiac function was eval-
uated by echocardiography and myocardial ﬁbrosis was detected by masson-trichrome
staining 4 weeks after MI. In vitro experiments were conducted on cultured neonatal
rat ventricular cardiomyocytes. Real-time PCR and western blot were performed to
determine the expression levels of the molecules involved in the study.
Results: The infarcted heart showed increased SphK1 expression and increased S1P
content. S1PR1, the predominant type of S1P receptors expressed in left ventricle, was
upregulated by 3-fold in cardiac tissue following MI (n¼6, all P<0.05). Further, we
observed that S1P signiﬁcantly activated NF-kB/STAT3 signaling and upregulated
pro-inﬂammatory cytokines (TNF-a and IL-6) expression in a dose-dependent manner
in cultured cardiomyocytes (n¼3, all P<0.01), all of which were almost blocked by
pretreatment with S1PR1 siRNA or FTY720, a functional S1PR1 inhibitor (n¼3, all
P<0.01). In vivo, administration of FTY720 decreased SphK1/S1P/S1PR1 axis,
inhibited persistent NF-kB/STAT3 signaling activation and blocked pro-inﬂammatory
cytokines production in post-MI heart. Accordingly, FTY720 remarkably alleviated
cardiac ﬁbrosis and dysfunction (ejection fraction: 35.53.0% vs. 29.42.7%,
P<0.05). Intriguingly, administration of SphK2 inhibitor ABC294640 ampliﬁed
cardiac SphK1/S1P/S1PR1 axis, augmented NF-kB/STAT3 signaling activation and
increased inﬂammatory cytokines expression. Consequently, SphK2 inhibition
reduced survival rate (68.4% vs. 83.3%, P<0.05) and exacerbated cardiac maladaptive
structural changes and ventricular dysfunction induced by MI (ejection fraction:
25.42.3% vs. 30.43.2%, P<0.05).
Conclusions: Our results provide the evidence that upregulated SphK1/S1P/S1PR1
signaling axis links persistent NF-kB/STAT3 activation, chronic cardiac inﬂammation
and heart failure progression following MI, whereas SphK2 serves as an endogenous
suppressor of pathological S1P signaling. Targeting SphK1/S1P/S1PR1 axis by
inhibiting SphK1 activity or enhancing SphK2 activity might be a potential thera-
peutic strategy for ischemic heart failure.asic and Translational Medicine C53
